Skip to content

Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis

Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02600689
Acronym
EXPLORE-IPF
Enrollment
20
Registered
2015-11-09
Start date
2015-08-31
Completion date
2018-03-16
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

Pulmonary rehab, Exergame, Home-based

Brief summary

Outpatient (phase 2) pulmonary rehab is an important, but mostly underutilized intervention to improve physical function in patients with idiopathic pulmonary fibrosis (IPF). Of those individuals who complete phase 2 pulmonary rehab, only a small cohort continues with any type of maintenance exercise therapy (phase 3). This is largely due to personal factors, such as access to transportation, weather, scheduling difficulties, and cost. Little is known about how to enhance physical activity among patients with IPF. In addition, no studies have investigated the long-term maintenance strategies of physical training in patients with IPF. Thus, the purpose of this study is to test the feasibility and effectiveness of a home-based, pulmonary rehab program for patients with IPF. A randomized, blinded, clinical trial (RCT) design with two arms -- Wii Fit Plus exergame program and cognitive video gaming, with no active whole body movement involved - will be used to investigate the benefits of a home-based exergame program on improving pulmonary-related function and symptoms in patients with IPF.

Interventions

BEHAVIORALCognitive exercise training

Sponsors

Pulmonary Fibrosis Foundation
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* confirmed diagnosis of IPF based on the criteria of the American Thoracic Society/European Respiratory Society 2011 guidelines; * ≥ 40 years-of-age; * ambulatory without the use of an assistive device; * stable clinical condition (i.e., no pulmonary exacerbation for at least 6 weeks); * no changes in medication for at least 4 weeks before enrollment; * currently sedentary (i.e., exercise or participate in sports less than 3 times per week for 20 min in the past 6 months) and do not play any exergames; * report dyspnea on exertion leading to a limitation in performing daily activities (i.e., Medical Research Council (MRC) dyspnea grade \>1); * able to read and follow exercise directions in English on the television screen; * have permission from their treating physician to participate in moderate-intensity exercise; * able to provide informed consent by understanding the nature of study participation.

Exclusion criteria

* contraindication for moderate-intensity exercise (e.g., unstable cardiac disease), * severe musculoskeletal, vestibular, or neurological disorders limiting exercise performance, or inability to perform the 6-min walk test or 15-step test, * requires \> 6 lpm supplemental oxygen therapy via nasal cannula during exercise to maintain SpO2 \>88%; * MRC dyspnea grade 4 or 5; IPF patients with MRC dyspnea grade 4 or 5 have been reported to show little or no improvement, or deteriorated following pulmonary rehab; * stage 2 hypertension, * anemia (hemoglobin \< 8 g/dL); * collagen vascular disease; * obstructive lung disease, * non-parenchymal restrictive lung disease, * occupational lung disease (pneumoconiosis, hypersensitivity pneumonitis), * sarcoidosis, * other idiopathic interstitial pneumonia; * currently participating or have participated (in the past 30 days) in another clinical trial which can affect the outcomes of the proposed study; or * planning to move out of Alabama within the next 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Functional performance12 weeks6-min walk distance (m)

Secondary

MeasureTime frameDescription
15-Step Test: Time12 weekstime (sec) to complete 15-step test
15-Step Test: Exercise desaturation12 weeksLevel of desaturation (%) during 15-step test
Exercise dyspnea12 weeksDyspnea level (Borg CR10) after completing the 15-step test oximetry test
Physical activity level12 weeksTime (min) spent per week in moderate-vigorous physical activity (assessed via an accelerometer)
Health-related quality of life12 weeksSt George's Respiratory Questionnaire
15-Step Test: Recovery12 weeksTime to recovery to baseline oxygen saturation following 15-step test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026